Name | Number of supported studies | Average coverage | |
---|---|---|---|
GABAergic neuron | 3 studies | 20% ± 3% | |
glutamatergic neuron | 3 studies | 24% ± 4% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 19% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 1047.13 | 2641 / 2642 | 100% | 7.37 | 705 / 705 |
prostate | 100% | 1047.93 | 245 / 245 | 100% | 4.89 | 501 / 502 |
thymus | 100% | 1306.73 | 653 / 653 | 100% | 6.93 | 602 / 605 |
kidney | 100% | 840.74 | 89 / 89 | 98% | 5.39 | 887 / 901 |
adrenal gland | 100% | 882.00 | 258 / 258 | 98% | 5.16 | 226 / 230 |
ovary | 100% | 1138.16 | 180 / 180 | 98% | 4.03 | 421 / 430 |
pancreas | 99% | 507.75 | 326 / 328 | 98% | 4.75 | 174 / 178 |
breast | 100% | 830.71 | 459 / 459 | 94% | 5.02 | 1053 / 1118 |
skin | 100% | 675.87 | 1808 / 1809 | 93% | 4.15 | 439 / 472 |
lung | 100% | 858.51 | 576 / 578 | 93% | 3.28 | 1075 / 1155 |
bladder | 100% | 988.67 | 21 / 21 | 91% | 4.44 | 458 / 504 |
stomach | 99% | 712.29 | 357 / 359 | 91% | 2.90 | 259 / 286 |
uterus | 100% | 1161.35 | 170 / 170 | 89% | 3.36 | 408 / 459 |
esophagus | 99% | 815.87 | 1436 / 1445 | 87% | 3.35 | 159 / 183 |
intestine | 100% | 980.02 | 965 / 966 | 86% | 2.46 | 451 / 527 |
liver | 99% | 426.49 | 224 / 226 | 61% | 1.41 | 246 / 406 |
spleen | 100% | 1291.84 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 11.90 | 1 / 1 |
adipose | 100% | 742.78 | 1203 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 762.21 | 1332 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 544.56 | 850 / 861 | 0% | 0 | 0 / 0 |
muscle | 97% | 387.62 | 780 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 97% | 3.51 | 28 / 29 |
tonsil | 0% | 0 | 0 / 0 | 96% | 3.31 | 43 / 45 |
eye | 0% | 0 | 0 / 0 | 95% | 3.35 | 76 / 80 |
peripheral blood | 57% | 345.54 | 533 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0051607 | Biological process | defense response to virus |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0005730 | Cellular component | nucleolus |
GO_0005829 | Cellular component | cytosol |
GO_0005634 | Cellular component | nucleus |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0003700 | Molecular function | DNA-binding transcription factor activity |
GO_0000977 | Molecular function | RNA polymerase II transcription regulatory region sequence-specific DNA binding |
GO_0005515 | Molecular function | protein binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0001227 | Molecular function | DNA-binding transcription repressor activity, RNA polymerase II-specific |
GO_0046872 | Molecular function | metal ion binding |
Gene name | ZNF175 |
Protein name | Zinc finger protein 175 (Zinc finger protein OTK18) Zinc finger protein 175 Alternative protein ZNF175 |
Synonyms | hCG_91953 |
Description | FUNCTION: Down-regulates the expression of several chemokine receptors. Interferes with HIV-1 replication by suppressing Tat-induced viral LTR promoter activity. . |
Accessions | L8E9H5 ENST00000262259.7 ENST00000545217.5 G3V1K8 M0R013 F5GZI7 Q9Y473 ENST00000596504.1 ENST00000436511.2 |